Orvosi Hetilap
Volume/Issue:
Volume 153: Issue 14
Leukemia- and lymphoma-associated flow cytometric, cytogenetic, and molecular genetic aberrations in healthy individuals
Authors:
János Jakó Jósa András Oktatókórház Egészségügyi Szolgáltató Nonprofit Kft. Hematológiai Osztály Nyíregyháza Lukács Ödön u. 4. 4400

Search for other papers by János Jakó in
Current site
Google Scholar
PubMed Close
and
László Szerafin Jósa András Oktatókórház Egészségügyi Szolgáltató Nonprofit Kft. Hematológiai Osztály Nyíregyháza Lukács Ödön u. 4. 4400

Search for other papers by László Szerafin in
Current site
Google Scholar
PubMed Close
Pages:
531–540
Online Publication Date:
26 Mar 2012
Publication Date:
01 Apr 2012
Article Category:
Research Article
DOI:
https://doi.org/10.1556/oh.2012.29334
Keywords:
monoklonális B-sejtes lymphocytosis; t(14;18)-transzlokáció; t(11;14)-transzlokáció; NPM-ALK fúziós gén; JAK2 V617F-mutáció; BCR-ABL1 fúziós gén; ETV6-RUNX1(TEL-AML1) fúziós gén; MLL-AF4 fúziós gén; PML-RARA fúziós gén; egészségesek; monoclonal B-cell lymphocytosis; chromosomal translocations t(14;18); and t(11;14); NPM-ALK fusion gene; JAK2 V617F mutation; BCR-ABL1 fusion gene; ETV6-RUNX1(TEL-AML1) fusion gene; MLL-AF4 fusion gene; PML-RARA fusion gene; healthy individuals
Restricted access

A malignus hematológiai kórképek jelentős hányadát jellemző áramláscitometriai, citogenetikai és molekuláris genetikai eltérések kísérik, amelyek azonban nemritkán egészségesekben is kimutathatók. A szerzők a rendelkezésükre álló irodalom alapján összefoglalják a monoklonális B-sejtes lymphocytosisra vonatkozó ismereteket, majd ismertetik azokat az adatokat, amelyek a t(14;18) és a t(11;14) kromoszómatranszlokáció, az NPM-ALK fúziós gén, a JAK2 V617F-mutáció, a BCR-ABL1 fúziós gén, az ETV6-RUNX1(TEL-AML1), az MLL-AF4 és a PML-RARA fúziós gén egészségesekben is tapasztalható előfordulására utalnak. Ma sem egyértelműen eldöntött, hogy a nem betegek körében talált ilyen eltéréseknek mi a jelentősége. Az irodalmi áttekintésből kiderül, hogy elméleti és gyakorlati (diagnosztikus, prognosztikus és terápiás) szempontból egyaránt fontos kérdésről van szó. Orv. Hetil., 2012, 153, 531–540.

  • Bäsecke, J., Griesinger, F., Trümper, L., et al.: Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann. Hematol., 2002, 81, 64–75.

    Trümper L. , 'Leukemia- and lymphoma-associated genetic aberrations in healthy individuals ' (2002 ) 81 Ann. Hematol. : 64 -75 .

    • Search Google Scholar

  • Janz, S., Potter, M., Rabkin, C. S.: Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer, 2003, 36, 211–223.

    Rabkin C. S. , 'Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals ' (2003 ) 36 Genes Chromosomes Cancer : 211 -223 .

    • Search Google Scholar

  • Brassesco, M. S.: Leukemia/lymphoma-associated gene fusions in normal individuals. Genet. Mol. Res., 2008, 7, 782–790.

    Brassesco M. S. , 'Leukemia/lymphoma-associated gene fusions in normal individuals ' (2008 ) 7 Genet. Mol. Res. : 782 -790 .

    • Search Google Scholar

  • Song, J., Mercer, D., Hu, X., et al.: Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals. J. Mol. Diagn., 2011, 13, 213–219.

    Hu X. , 'Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals ' (2011 ) 13 J. Mol. Diagn. : 213 -219 .

    • Search Google Scholar

  • Han, T., Ozer, H., Gavigan, M., et al.: Benign monoclonal B cell lymphocytosis – a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood, 1984, 64, 244–252.

    Gavigan M. , 'Benign monoclonal B cell lymphocytosis – a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients ' (1984 ) 64 Blood : 244 -252 .

    • Search Google Scholar

  • Marti, G. E., Rawstron, A. C., Ghia, P., et al.: Diagnosic criteria for monoclonal B-cell lymphocytosis. Br. J. Haematol., 2005, 130, 325–332.

    Ghia P. , 'Diagnosic criteria for monoclonal B-cell lymphocytosis ' (2005 ) 130 Br. J. Haematol. : 325 -332 .

    • Search Google Scholar

  • Rawstron, A. C., Green, M. J., Kuzmicki, A., et al.: Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3,5% of adults with normal blood counts. Blood, 2002, 100, 635–639.

    Kuzmicki A. , 'Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3,5% of adults with normal blood counts ' (2002 ) 100 Blood : 635 -639 .

    • Search Google Scholar

  • Fazi, C., Scarfó, L., Pecciarini, L., et al.: General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood, 2011, 118, 6618–6625.

    Pecciarini L. , 'General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL ' (2011 ) 118 Blood : 6618 -6625 .

    • Search Google Scholar

  • Scarfó, L., Dagklis, A., Scielzo, C., et al.: CLL-like monoclonal B-lymphocytosis: Are we all bound to have it? Semin. Cancer Biol., 2010, 20, 384–390.

    Scielzo C. , 'CLL-like monoclonal B-lymphocytosis: Are we all bound to have it? ' (2010 ) 20 Semin. Cancer Biol. : 384 -390 .

    • Search Google Scholar

  • Marti, G. E.: MBL: mostly benign lymphocytes, but…. Blood, 2011, 118, 6480–6481.

    Marti G. E. , 'MBL: mostly benign lymphocytes, but… ' (2011 ) 118 Blood : 6480 -6481 .

    • Search Google Scholar

  • Rawstron, A. C., Hillmen, P.: Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract. Res. Clin. Haematol., 2010, 23, 61–69.

    Hillmen P. , 'Clinical and diagnostic implications of monoclonal B-cell lymphocytosis ' (2010 ) 23 Best Pract. Res. Clin. Haematol. : 61 -69 .

    • Search Google Scholar

  • Ghia, P.: Another piece of the puzzle: is there a “nodal” monoclonal B-cell lymphocytosis? Haematologica, 2011, 96, 1089–1091.

    Ghia P. , 'Another piece of the puzzle: is there a “nodal” monoclonal B-cell lymphocytosis? ' (2011 ) 96 Haematologica : 1089 -1091 .

    • Search Google Scholar

  • Nieto, W. G., Teodosio, C., López, A., et al.: Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics. Cytometry B Clin. Cytom., 2010, 78 (Suppl. 1), S24–S34.

    López A. , 'Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics ' (2010 ) 78 Cytometry B Clin. Cytom. : S24 -S34 .

    • Search Google Scholar

  • Rawstron, A. C., Bennett, F. L., O’Connor, S. J. M., et al.: Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N. Engl. J. Med., 2008, 359, 575–583.

    O’Connor S. J. M. , 'Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia ' (2008 ) 359 N. Engl. J. Med. : 575 -583 .

    • Search Google Scholar

  • Shanafelt, T. D., Hanson, C. A.: Monoclonal B-cell lymphocytosis: definitions and natural history. Leuk. Lymphoma, 2009, 50, 493–497.

    Hanson C. A. , 'Monoclonal B-cell lymphocytosis: definitions and natural history ' (2009 ) 50 Leuk. Lymphoma : 493 -497 .

    • Search Google Scholar

  • Shanafelt, T. D., Kay, N. E., Jenkins, G., et al.: B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood, 2009, 113, 4188–4196.

    Jenkins G. , 'B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome ' (2009 ) 113 Blood : 4188 -4196 .

    • Search Google Scholar

  • Marti, G. E.: The changing definition of CLL. Blood, 2009, 113, 4130–4131.

    Marti G. E. , 'The changing definition of CLL ' (2009 ) 113 Blood : 4130 -4131 .

  • Molica, S., Mauro, F. R., Giannarelli, D., et al.: Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica, 2011, 96, 277–283.

    Giannarelli D. , 'Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group ' (2011 ) 96 Haematologica : 277 -283 .

    • Search Google Scholar

  • Shanafelt, T. D., Ghia, P., Lanasa, M. C., et al.: Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia, 2010, 24, 512–520.

    Lanasa M. C. , 'Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management ' (2010 ) 24 Leukemia : 512 -520 .

    • Search Google Scholar

  • Hanson, C. A., Kurtin, P. J., Dogan, A.: The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences? Blood, 2009, 113, 6495–6496.

    Dogan A. , 'The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences? ' (2009 ) 113 Blood : 6495 -6496 .

    • Search Google Scholar

  • Mulligan, C. S., Thomas, M. E., Mulligan, S. P.: Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for chronic lymphocytic leukemia (CLL). Blood, 2009, 113, 6496–6497.

    Mulligan S. P. , 'Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for chronic lymphocytic leukemia (CLL) ' (2009 ) 113 Blood : 6496 -6497 .

    • Search Google Scholar

  • Gibson, S. E., Swerdlow, S. H., Ferry, J. A., et al.: Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica, 2011, 96, 1144–1152.

    Ferry J. A. , 'Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis ' (2011 ) 96 Haematologica : 1144 -1152 .

    • Search Google Scholar

  • Rawstron, A. C., Bennett, F., Hillmen, P.: The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia. Br. J. Haematol., 2007, 139, 724–729.

    Hillmen P. , 'The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia ' (2007 ) 139 Br. J. Haematol. : 724 -729 .

    • Search Google Scholar

  • Rawstron, A. C., Shingles, J., de Tute, R., et al.: Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing. Cytometry B Clin. Cytom., 2010, 78 (Suppl. 1), S42–S46.

    Tute R. , 'Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing ' (2010 ) 78 Cytometry B Clin. Cytom. : S42 -S46 .

    • Search Google Scholar

  • Gutierrez, A. Jr., Tschumper, R. C., Wu, X., et al.: LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood, 2010, 116, 2975–2983.

    Wu X. , 'LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis ' (2010 ) 116 Blood : 2975 -2983 .

    • Search Google Scholar

  • Crowther-Swanepoel, D., Corre, T., Lloyd, A., et al.: Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. Blood, 2010, 116, 5957–5960.

    Lloyd A. , 'Inherited genetic susceptibility to monoclonal B-cell lymphocytosis ' (2010 ) 116 Blood : 5957 -5960 .

    • Search Google Scholar

  • Shanafelt, T. D., Kay, N. E., Rabe, K. G., et al.: Natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J. Clin. Oncol., 2009, 27, 3959–3963.

    Rabe K. G. , 'Natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia ' (2009 ) 27 J. Clin. Oncol. : 3959 -3963 .

    • Search Google Scholar

  • Fung, S. S., Hillier, K. L., Leger, C. S., et al.: Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk. Lymph., 2007, 48, 1087–1091.

    Leger C. S. , 'Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis ' (2007 ) 48 Leuk. Lymph. : 1087 -1091 .

    • Search Google Scholar

  • Rossi, D., Sozzi, E., Puma, A., et al.: The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br. J. Haematol., 2009, 146, 64–75.

    Puma A. , 'The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors ' (2009 ) 146 Br. J. Haematol. : 64 -75 .

    • Search Google Scholar

  • Goldin, L. R., Lanasa, M. C., Slager, S. L., et al.: Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br. J. Haematol., 2010, 151, 152–158.

    Slager S. L. , 'Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families ' (2010 ) 151 Br. J. Haematol. : 152 -158 .

    • Search Google Scholar

  • Del Giudice, I., Mauro, F. R., De Propris, M. S., et al.: Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients. Blood, 2009, 114, 2848–2849.

    Propris M. S. , 'Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients ' (2009 ) 114 Blood : 2848 -2849 .

    • Search Google Scholar

  • De Tute, R., Yuille, M., Catovsky, D., et al.: Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia, 2006, 20, 728–729.

    Catovsky D. , 'Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults ' (2006 ) 20 Leukemia : 728 -729 .

    • Search Google Scholar

  • Matos, D. M., Ismael, S. J., Scrideli, C. A., et al.: Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. Br. J. Haematol., 2009, 147, 339–346.

    Scrideli C. A. , 'Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia ' (2009 ) 147 Br. J. Haematol. : 339 -346 .

    • Search Google Scholar

  • Rawstron, A. C., Yuille, M. R., Fuller, J., et al.: Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood, 2002, 100, 2289–2290.

    Fuller J. , 'Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion ' (2002 ) 100 Blood : 2289 -2290 .

    • Search Google Scholar

  • Hardy, N. M., Grady, C., Pentz, R., et al.: Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br. J. Haematol., 2007, 139, 824–831.

    Pentz R. , 'Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation ' (2007 ) 139 Br. J. Haematol. : 824 -831 .

    • Search Google Scholar

  • Nahi, H., Jansson, M., Sander, B., et al.: Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient. Br. J. Haematol., 2008, 143, 744–755.

    Sander B. , 'Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient ' (2008 ) 143 Br. J. Haematol. : 744 -755 .

    • Search Google Scholar

  • Marti, G., Abbasi, F., Raveche, E., et al.: Overview of monoclonal B-cell lymphocytosis. Br. J. Haematol., 2007, 139, 701–708.

    Raveche E. , 'Overview of monoclonal B-cell lymphocytosis ' (2007 ) 139 Br. J. Haematol. : 701 -708 .

    • Search Google Scholar

  • Rachel, J. M., Zucker, M. L., Fox, C. M., et al.: Monoclonal B-cell lymphocytosis in blood donors. Br. J. Haematol., 2007, 139, 832–836.

    Fox C. M. , 'Monoclonal B-cell lymphocytosis in blood donors ' (2007 ) 139 Br. J. Haematol. : 832 -836 .

    • Search Google Scholar

  • Vogt, R. F., Shim, Y. K., Middleton, D. C., et al.: Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br. J. Haematol., 2007, 139, 690–700.

    Middleton D. C. , 'Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies ' (2007 ) 139 Br. J. Haematol. : 690 -700 .

    • Search Google Scholar

  • Linet, M. S., Schubauer-Berigan, M. K., Weisenburger, D. D., et al.: Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogensis. Br. J. Haematol., 2007, 139, 672–686.

    Weisenburger D. D. , 'Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogensis ' (2007 ) 139 Br. J. Haematol. : 672 -686 .

    • Search Google Scholar

  • Lanasa, M. C., Allgood, S. D., Weinberg, J. B.: Monoclonal B cell lymphocytosis. Leuk. Lymphoma, 2010, 51, 1386–1388.

    Weinberg J. B. , 'Monoclonal B cell lymphocytosis ' (2010 ) 51 Leuk. Lymphoma : 1386 -1388 .

    • Search Google Scholar

  • Dölken, L., Schüler, F., Dölken, G.: Frequency of BCL-2/JH translocation in healthy males exposed to low-level radiation in comparison to age-matched healthy controls. Blood, 2002, 100, 1513–1514.

    Dölken G. , 'Frequency of BCL-2/JH translocation in healthy males exposed to low-level radiation in comparison to age-matched healthy controls ' (2002 ) 100 Blood : 1513 -1514 .

    • Search Google Scholar

  • Roulland, S., Lebailly, P., Lecluse, Y., et al.: Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia, 2006, 20, 158–162.

    Lecluse Y. , 'Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals ' (2006 ) 20 Leukemia : 158 -162 .

    • Search Google Scholar

  • Chiu, B. C-H., Lan, Q., Dave, B. J., et al.: The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J. Natl. Cancer Inst. Monogr., 2008, 39, 69–73.

    Dave B. J. , 'The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma ' (2008 ) 39 J. Natl. Cancer Inst. Monogr. : 69 -73 .

    • Search Google Scholar

  • Hirt, C., Dölken, G., Janz, S., et al.: Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals. Br. J. Haematol., 2007, 138, 349–353.

    Janz S. , 'Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals ' (2007 ) 138 Br. J. Haematol. : 349 -353 .

    • Search Google Scholar

  • Dölken, G., Dölken, L., Hirt, C., et al.: Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. J. Natl. Cancer Inst. Monogr., 2008, 39, 44–47.

    Hirt C. , 'Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals ' (2008 ) 39 J. Natl. Cancer Inst. Monogr. : 44 -47 .

    • Search Google Scholar

  • Liu, Y., Hernandez, A. M., Shibata, D., et al.:BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA, 1994, 91, 8910–8914.

    Shibata D. , 'BCL2 translocation frequency rises with age in humans ' (1994 ) 91 Proc. Natl. Acad. Sci. USA : 8910 -8914 .

    • Search Google Scholar

  • Ji, W., Qu, G., Ye, P., et al.: Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res., 1995, 55, 2876–2882.

    Ye P. , 'Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay ' (1995 ) 55 Cancer Res. : 2876 -2882 .

    • Search Google Scholar

  • Baccarelli, A., Hirt, C., Pesatori, A. C., et al.: t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis, 2006, 27, 2001–2007.

    Pesatori A. C. , 't(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy ' (2006 ) 27 Carcinogenesis : 2001 -2007 .

    • Search Google Scholar

  • Schüler, F., Dölken, L., Hirt, C., et al.: Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int. J. Cancer, 2009, 124, 958–963.

    Hirt C. , 'Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals ' (2009 ) 124 Int. J. Cancer : 958 -963 .

    • Search Google Scholar

  • Limpens, J., Stad, R., Vos, C., et al.: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood, 1995, 85, 2528–2536.

    Vos C. , 'Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals ' (1995 ) 85 Blood : 2528 -2536 .

    • Search Google Scholar

  • Dölken, G., Illerhaus, G., Hirt, C., et al.: BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J. Clin. Oncol., 1996, 14, 1333–1344.

    Hirt C. , 'BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases ' (1996 ) 14 J. Clin. Oncol. : 1333 -1344 .

    • Search Google Scholar

  • Schüler, F., Hirt, C., Dölken, G.: Chromosomal translocation t(14;18) in healthy individuals. Semin. Cancer Biol., 2003, 13, 203–209.

    Dölken G. , 'Chromosomal translocation t(14;18) in healthy individuals ' (2003 ) 13 Semin. Cancer Biol. : 203 -209 .

    • Search Google Scholar

  • Rabkin, C. S., Hirt, C., Janz, S., et al.: t(14;18) translocations and risk of follicular lymphoma. J. Natl. Cancer Inst. Monogr., 2008, 39, 48–51.

    Janz S. , 't(14;18) translocations and risk of follicular lymphoma ' (2008 ) 39 J. Natl. Cancer Inst. Monogr. : 48 -51 .

    • Search Google Scholar

  • Yasukawa, M., Bando, S., Dölken, G., et al.: Low frequency of BCL-2/JH translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood, 2001, 98, 486–488.

    Dölken G. , 'Low frequency of BCL-2/JH translocation in peripheral blood lymphocytes of healthy Japanese individuals ' (2001 ) 98 Blood : 486 -488 .

    • Search Google Scholar

  • Nambiar, M., Raghavan, S. C.: Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population. Ann. Hematol., 2010, 89, 35–43.

    Raghavan S. C. , 'Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population ' (2010 ) 89 Ann. Hematol. : 35 -43 .

    • Search Google Scholar

  • Summers, K. E., Goff, L. K., Wilson, A. G., et al.: Frequency of the Bcl-2/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma. J. Clin. Oncol., 2001, 19, 420–424.

    Wilson A. G. , 'Frequency of the Bcl-2/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma ' (2001 ) 19 J. Clin. Oncol. : 420 -424 .

    • Search Google Scholar

  • McHale, C. M., Lan, Q., Corso, C., et al.: Chromosome translocations in workers exposed to benzene. J. Natl. Cancer Inst. Monogr., 2008, 39, 74–77.

    Corso C. , 'Chromosome translocations in workers exposed to benzene ' (2008 ) 39 J. Natl. Cancer Inst. Monogr. : 74 -77 .

    • Search Google Scholar

  • Sebők, P., Takács, I., Szabó, G., et al.: Appearance of the t(14;18) chromosome translocation in diseases of different types. [A t(14;18) kromoszóma-transzlokáció jelenléte különböző típusú betegségekben.]. Orv. Hetil., 1997, 138, 3301–3305. [Hungarian]

    Szabó G. , 'Appearance of the t(14;18) chromosome translocation in diseases of different types. [A t(14;18) kromoszóma-transzlokáció jelenléte különböző típusú betegségekben.] ' (1997 ) 138 Orv. Hetil. : 3301 -3305 .

    • Search Google Scholar

  • Semsei, I., Zeher, M., Takács, I., et al.: Occurrence of t(14;18) chromosome translocation in lymphocytes of patients with primary Sjögren’s syndrome. [A t(14;18) kromoszóma transzlokáció előfordulása primer Sjögren-szindrómás betegek lymphocytáiban.]. Magy. Belorv. Arch., 1998, 51, 249–254. [Hungarian]

    Takács I. , 'Occurrence of t(14;18) chromosome translocation in lymphocytes of patients with primary Sjögren’s syndrome. [A t(14;18) kromoszóma transzlokáció előfordulása primer Sjögren-szindrómás betegek lymphocytáiban.] ' (1998 ) 51 Magy. Belorv. Arch. : 249 -254 .

    • Search Google Scholar

  • Sevilla, D. W., Murty, V. V., Sun, X-L., et al.: Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma? Hematol. Oncol., 2011, 29, 81–90.

    Sun X-L. , 'Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma? ' (2011 ) 29 Hematol. Oncol. : 81 -90 .

    • Search Google Scholar

  • Bretherick, K. L., Bu, R., Gascoyne, R. D., et al.: Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma. Blood, 2010, 116, 6146–6147.

    Gascoyne R. D. , 'Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma ' (2010 ) 116 Blood : 6146 -6147 .

    • Search Google Scholar

  • Jegalian, A. G., Eberle, F. C., Pack, S. D., et al.: Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood, 2011, 118, 2976–2984.

    Pack S. D. , 'Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma ' (2011 ) 118 Blood : 2976 -2984 .

    • Search Google Scholar

  • Espinet, B., Solé, F., Pedro, C., et al.: Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum. Pathol., 2005, 36, 1232–1237.

    Pedro C. , 'Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? ' (2005 ) 36 Hum. Pathol. : 1232 -1237 .

    • Search Google Scholar

  • Hirt, C., Schüler, F., Dölken, L., et al.: Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood, 2004, 104, 904–905.

    Dölken L. , 'Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR ' (2004 ) 104 Blood : 904 -905 .

    • Search Google Scholar

  • Lecluse, Y., Lebailly, P., Roulland, S., et al.: t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia, 2009, 23, 1190–1193.

    Roulland S. , 't(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals ' (2009 ) 23 Leukemia : 1190 -1193 .

    • Search Google Scholar

  • Trümper, L., Pfreundschuh, M., Bonin, F. V., et al.: Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br. J. Haematol., 1998, 103, 1138–1144.

    Bonin F. V. , 'Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals ' (1998 ) 103 Br. J. Haematol. : 1138 -1144 .

    • Search Google Scholar

  • Maes, B., Vanhentenrijk, V., Wlodarska, I., et al.: The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am. J. Pathol., 2001, 158, 2185–2193.

    Wlodarska I. , 'The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells ' (2001 ) 158 Am. J. Pathol. : 2185 -2193 .

    • Search Google Scholar

  • Passamonti, F., Rumi, E., Pietra, D., et al.:JAK2 (V617F) mutation in healthy individuals. Br. J. Haematol., 2007, 136, 677–679.

    Pietra D. , 'JAK2 (V617F) mutation in healthy individuals ' (2007 ) 136 Br. J. Haematol. : 677 -679 .

    • Search Google Scholar

  • Martinaud, C., Brisou, P., Mozziconacci, M. J.: Is the JAK2V617F mutation detectable in healthy volunteers? Am. J. Hematol., 2010, 85, 287–288.

    Mozziconacci M. J. , 'Is the JAK2V617F mutation detectable in healthy volunteers? ' (2010 ) 85 Am. J. Hematol. : 287 -288 .

    • Search Google Scholar

  • Sidon, P., El Housni, H., Dessars, B., et al.: The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors. Leukaemia, 2006, 20, 1622.

    Dessars B. , 'The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors ' (2006 ) 20 Leukaemia : 1622 -.

    • Search Google Scholar

  • Xu, X., Zhang, Q., Luo, J., et al.: JAK2V617F: prevalence in a large Chinese hospital population. Blood, 2007, 109, 339–342.

    Luo J. , 'JAK2V617F: prevalence in a large Chinese hospital population ' (2007 ) 109 Blood : 339 -342 .

    • Search Google Scholar

  • Bellanné-Chantelot, C., Jego, P., Lionne-Huyghe, P., et al.: The JAK2V617F mutation may be present several years before the occurrence of overt myeloproliferative disorders. Leukemia, 2008, 22, 450–451.

    Lionne-Huyghe P. , 'The JAK2V617F mutation may be present several years before the occurrence of overt myeloproliferative disorders ' (2008 ) 22 Leukemia : 450 -451 .

    • Search Google Scholar

  • Nielsen, C., Birgens, H. S., Nordestgaard, B. G., et al.: The JAK2 V617F somatic mutation, mortality and cancer risk in the general population. Haematologica, 2011, 96, 450–453.

    Nordestgaard B. G. , 'The JAK2 V617F somatic mutation, mortality and cancer risk in the general population ' (2011 ) 96 Haematologica : 450 -453 .

    • Search Google Scholar

  • Biernaux, C., Loos, M., Sels, A., et al.: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood, 1995, 86, 3118–3122.

    Sels A. , 'Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals ' (1995 ) 86 Blood : 3118 -3122 .

    • Search Google Scholar

  • Bose, S., Deininger, M., Gora-Tybor, J., et al.: The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood, 1998, 92, 3362–3367.

    Gora-Tybor J. , 'The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease ' (1998 ) 92 Blood : 3362 -3367 .

    • Search Google Scholar

  • Butt, N. M., Rojas, J. M., Wang, L., et al.: Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects. Haematologica, 2005, 90, 1315–1323.

    Wang L. , 'Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects ' (2005 ) 90 Haematologica : 1315 -1323 .

    • Search Google Scholar

  • Hunger, S. P., Cleary, M. L.: What significance should we attribute to the detection of MLL fusion transcripts? Blood, 1998, 92, 709–711.

    Cleary M. L. , 'What significance should we attribute to the detection of MLL fusion transcripts? ' (1998 ) 92 Blood : 709 -711 .

    • Search Google Scholar

  • Uckun, F. M., Herman-Hatten, K., Crotty, M. L., et al.: Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood, 1998, 92, 810–821.

    Crotty M. L. , 'Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation ' (1998 ) 92 Blood : 810 -821 .

    • Search Google Scholar

  • Trka, J., Zuna, J., Hrusák, O., et al.: No evidence for MLL/AF4 expression in normal cord blood samples. Blood, 1999, 93, 1106–1107.

    Hrusák O. , 'No evidence for MLL/AF4 expression in normal cord blood samples ' (1999 ) 93 Blood : 1106 -1107 .

    • Search Google Scholar

  • Kim-Rouille, M. H., MacGregor, A., Wiedemann, L. M., et al.:MLL-AF4 gene fusions in normal newborns. Blood, 1999, 93, 1107–1108.

    Wiedemann L. M. , 'MLL-AF4 gene fusions in normal newborns ' (1999 ) 93 Blood : 1107 -1108 .

    • Search Google Scholar

  • Montes, R., Ayllón, V., Gutierrez-Aranda, I., et al.: Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. Blood, 2011, 117, 4746–4758.

    Gutierrez-Aranda I. , 'Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia ' (2011 ) 117 Blood : 4746 -4758 .

    • Search Google Scholar

  • Uckun, F. M.: MLL-AF4 fusion transcripts in normal and leukemic hematopoietic cells. Blood, 1999, 93, 1109–1110.

    Uckun F. M. , 'MLL-AF4 fusion transcripts in normal and leukemic hematopoietic cells ' (1999 ) 93 Blood : 1109 -1110 .

    • Search Google Scholar

  • Brassesco, M. S., Montaldi, A. P., Gras, D. E., et al.: MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals. Genet. Mol. Biol., 2009, 32, 234–241.

    Gras D. E. , 'MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals ' (2009 ) 32 Genet. Mol. Biol. : 234 -241 .

    • Search Google Scholar

  • Schnittger, S., Wörmann, B., Hiddemann, W., et al.: Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood, 1998, 92, 1728–1734.

    Hiddemann W. , 'Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors ' (1998 ) 92 Blood : 1728 -1734 .

    • Search Google Scholar

  • Brown, P.: TEL-AML1 in cord blood: 1% or 0.01%? Blood, 2011, 117, 2–4.

    Brown P. , 'TEL-AML1 in cord blood: 1% or 0.01%? ' (2011 ) 117 Blood : 2 -4 .

  • Mori, H., Colman, S. M., Xiao, Z., et al.: Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA, 2002, 99, 8242–8247.

    Xiao Z. , 'Chromosome translocations and covert leukemic clones are generated during normal fetal development ' (2002 ) 99 Proc. Natl. Acad. Sci. USA : 8242 -8247 .

    • Search Google Scholar

  • Lausten-Thomsen, U., Madsen, H. O., Vestergaard, T. R., et al.: Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates. Blood, 2011, 117, 186–189.

    Vestergaard T. R. , 'Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates ' (2011 ) 117 Blood : 186 -189 .

    • Search Google Scholar

  • Greaves, M., Colman, S. M., Kearney, L., et al.: Fusion genes in cord blood. Blood, 2011, 117, 369–370.

    Kearney L. , 'Fusion genes in cord blood ' (2011 ) 117 Blood : 369 -370 .

  • Quina, A. S., Gameiro, P., Sá da Costa, M., et al.:PML-RARA fusion transcripts in irradiated and normal hematopoietic cells. Genes Chromosomes Cancer, 2000, 29, 266–275.

    Sá da Costa M. , 'PML-RARA fusion transcripts in irradiated and normal hematopoietic cells ' (2000 ) 29 Genes Chromosomes Cancer : 266 -275 .

    • Search Google Scholar
  • Collapse
  • Expand
Cover Orvosi Hetilap
Orvosi Hetilap
Print ISSN:
0030-6002
Online ISSN:
1788-6120

Főszerkesztő - Editor-in-Chief:
 
Zoltán PAPP (professor emeritus, Semmelweis Egyetem, Szülészeti és Nőgyógyászati Klinika, Budapest)

Read the professional career of Zoltán PAPP HERE.

All scientific publications of Zoltán PAPP are collected in the Hungarian Scientific Bibliography.

Főszerkesztő-helyettesek - Assistant Editors-in-Chief: 

  • Erzsébet FEHÉR (professor emeritus, Semmelweis Egyetem, Anatómiai, Szövet- és Fejlődéstani Intézet)
  • Krisztina HAGYMÁSI (egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)

Főmunkatársak - Senior Editorial Specialists:

  • László KISS (a Debreceni Egyetem habilitált doktora)
  • Gabriella LENGYEL (ny. egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)
  • Alajos PÁR (professor emeritus, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)

 A Szerkesztőbizottság tagjai – Members of the Editorial Board:

  • Péter ANDRÉKA (főigazgató, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • Géza ÁCS Jr. (egyetemi tanár Floridában)
  • Csaba BALÁZS (egyetemi tanár, Budai Endokrinközpont, Budapest)
  • Zoltán BENYÓ (egyetemi tanár, Semmelweis Egyetem, Transzlációs Medicina Intézet, Budapest)
  • Dániel BERECZKI (egyetemi tanár, Semmelweis Egyetem, Neurológiai Klinika, Budapest)
  • Anna BLÁZOVICS (professor emeritus, Semmelweis Egyetem, Farmakognóziai Intézet, Budapest)
  • Lajos BOGÁR (egyetemi tanár, Pécsi Tudományegyetem, Klinikai Központ, Aneszteziológiai és Intenzív Terápiás Intézet, Pécs)
  • Katalin DARVAS (professor emeritus, Semmelweis Egyetem, Általános Orvostudományi Kar, Sebészeti, Transzplantációs és Gasztroenterológiai Klinika, továbbá Aneszteziológiai és Intenzív Terápiás Klinika, Budapest)
  • Elek DINYA (professor emeritus, biostatisztikus, Semmelweis Egyetem, Budapest)
  • Attila DOBOZY (professor emeritus, Szegedi Tudományegyetem, Bőrgyógyászati Klinika, Szeged)
  • Levente EMŐDY (professor emeritus, Pécsi Tudományegyetem, Általános Orvostudományi Kar, Mikrobióligiai Intézet, Pécs)
  • András FALUS (professor emeritus, Semmelweis Egyetem, Genetikai, Sejt- és Immunbiológiai Intézet, Budapest)
  • Béla FÜLESDI (egyetemi tanár, Debreceni Egyetem, Aneszteziológiai és Intenzív Terápiás Klinika, Debrecen)
  • István GERA (professor emeritus, Semmelweis Egyetem, Fogorvostudományi Kar, Parodontológiai Klinika, Budapest)
  • Beáta GASZTONYI (egyetemi magántanár, kórházi főorvos, Zala Megyei Kórház, Belgyógyászat, Zalaegerszeg)
  • Béla GÖMÖR (professor emeritus, Budai Irgalmasrendi Kórház, Reumatológiai Osztály, Budapest)
  • János HANKISS (professor emeritus, Markusovszky Lajos Oktató Kórház, Belgyógyászati Osztály, Szombathely)
  • Katalin HEGEDŰS (habilitált egyetemi docens, Semmelweis Egyetem, Általános Orvosi Kar, Magatartástudományi Intézet, Budapest)
  • Andor HIRSCHBERG (c. egyetemi tanár, Észak-budai Szent János Centrumkórház, Fül-, Orr-, Gége-, Fej-Nyak és Szájsebészeti Osztály, Budapest)
  • Örs Péter HORVÁTH (professor emeritus, Pécsi Tudományegyetem, Sebészeti Klinika, Pécs)
  • Béla HUNYADY (egyetemi tanár, Somogy Megyei Kaposi Mór Kórház, Belgyógyászat, Kaposvár)
  • Péter IGAZ (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • Ferenc JAKAB (c. egyetemi tanár, Uzsoki Utcai Kórház, Sebészet, Budapest)
  • Zoltán JANKA (professor emeritus, Szegedi Tudományegyetem, Szent-Györgyi Albert Orvostudományi Kar és Klinikai Központ, Pszichiátriai Klinika, Szeged)
  • András JÁNOSI (c. egyetemi tanár, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • György JERMENDY (egyetemi tanár, Bajcsy-Zsilinszky Kórház, Belgyógyászat, Budapest)
  • László KALABAY (egyetemi tanár, Semmelweis Egyetem, Családorvosi Tanszék, Budapest)
  • Anita KAMONDI (egyetemi tanár, Országos Mentális, Ideggyógyászati és Idegsebészeti Intézet, Neurológiai Osztály, Budapest)
  • János KAPPELMAYER (egyetemi tanár, Debreceni Egyetem, Laboratóriumi Medicina Intézet, Debrecen)
  • Éva KELLER (ny. egyetemi tanár, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • András KISS (egyetemi tanár, Semmelweis Egyetem, II. Patológiai Intézet, Budapest)
  • Lajos KULLMANN (ny. egyetemi tanár, Országos Rehabilitációs Intézet, Budapest)
  • Emese MEZŐSI (egyetemi tanár, Pécsi Tudományegyetem, I. Belgyógyászati Klinika, Pécs)
  • László MÓDIS (egyetemi tanár, Debreceni Egyetem, Általános Orvostudományi Kar, Szemészeti Tanszék, Debrecen)
  • Györgyi MŰZES (egyetemi docens, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Bálint NAGY (egyetemi tanár, Debreceni Egyetem, Humángenetikai Tanszék, Debrecen)
  • Endre NAGY (egyetemi tanár, Debreceni Egyetem, Belgyógyászati Intézet, Debrecen) 
  • Péter NAGY (egyetemi tanár, Semmelweis Egyetem, I. Patológiai és Kísérleti Rákkutató Intézet, Budapest)
  • Viktor NAGY (főorvos, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Zoltán Zsolt NAGY (egyetemi tanár, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • György PARAGH (professor emeritus, Debreceni Egyetem, Általános Orvostudományi Kar, Belgyógyászati Intézet, Debrecen)
  • Attila PATÓCS (tudományos főmunkatárs, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Edit PAULIK (intézetvezető egyetemi tanár, Szegedi Tudományegyetem, Szent-Györgyi Albert Orvostudományi Kar, Népegészségtani Intézet, Szeged)
  • Gabriella PÁR (egyetemi docens, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)
  • György PFLIEGLER (egyetemi tanár, Debreceni Egyetem, Ritka Betegségek Tanszéke, Debrecen)
  • István RÁCZ (egyetemi tanár, főorvos, Petz Aladár Megyei Oktató Kórház, Belgyógyászat, Győr)
  • Bernadette ROJKOVICH (osztályvezető főorvos, Betegápoló Irgalmasrend Budai Irgalmasrendi Kórház, Budapest)
  • Imre ROMICS (professor emeritus, Semmelweis Egyetem, Urológiai Klinika, Budapest)
  • László Jr. ROMICS (Angliában dolgozik)
  • Ferenc ROZGONYI (professor emeritus, Semmelweis Egyetem, Laboratóriumi Medicina Intézet, Budapest)
  • Imre RURIK (egyetemi tanár, Debreceni Egyetem, Családorvosi és Foglalkozás-egészségügyi Tanszék, Debrecen)
  • Péter SCHMIDT (házi gyermekorvos, Győr)
  • Gábor SIMONYI (vezető főorvos, Szent Imre Kórház, Anyagcsere Központ, Budapest)
  • Gábor Márk SOMFAI (egyetemi docens, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • Anikó SOMOGYI (ny. egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Péter SÓTONYI (professor emeritus, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • Péter Jr. SÓTONYI (egyetemi tanár, Semmelweis Egyetem, Városmajori Szív- és Érsebészeti Klinika, Budapest)
  • Ildikó SÜVEGES (professor emeritus, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • György SZABÓ (professor emeritus, Semmelweis Egyetem, Arc-Állcsont-Szájsebészeti és Fogászati Klinika, Budapest)
  • György SZEIFERT (egyetemi magántanár, Semmelweis Egyetem, Általános Orvostudományi Kar, Idegsebészeti Tanszék, Budapest)
  • Miklós SZENDRŐI (professor emeritus, Semmelweis Egyetem, Ortopédiai Klinika, Budapest)
  • Miklós TÓTH (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • László TRINGER (professor emeritus, Semmelweis Egyetem, Pszichiátriai és Pszichoterápiás Klinika, Budapest)
  • Tivadar TULASSAY (professor emeritus, Semmelweis Egyetem, I. Gyermekgyógyászati Klinika, Budapest)
  • Zsolt TULASSAY (professor emeritus, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Lívia VASAS (ny. könyvtárigazgató, Semmelweis Egyetem, Központi Könyvtár, Budapest)
  • Barna VÁSÁRHELYI (egyetemi tanár, Semmelweis Egyetem, Laboratóriumi Medicina Intézet, Budapest)
  • László VÉCSEI (professor emeritus, Szegedi Tudományegyetem, Neurológiai Klinika, Szeged)
  • Gábor WINKLER (egyetemi tanár, Szent János Kórház, Belgyógyászati Osztály, Budapest)

Nemzetközi szerkesztőbizottság - International Editorial Board:

  • Elnök/President Péter SÓTONYI (Budapest)
  • Ernest ADEGHATE (Al Ain)
  • Ferenc ANTONI (Edinburgh)
  • Maciej BANACH (Łódź)
  • Klára BERENCSI (Rosemont)
  • Angelo BIGNAMINI (Milano)
  • Anupam BISHAYEE (Signal Hill)
  • Hubert E. BLUM (Freiburg)
  • G. László BOROS (Los Angeles)
  • Frank A. CHERVENAK (New York)
  • József DÉZSY (Wien)
  • Peter ECKL (Salzburg)
  • Péter FERENCI (Wien)
  • Madelaine HAHN (Erlangen)
  • S. Tamás ILLÉS (Bruxelles)
  • Michael KIDD (Toronto)
  • Andrzej KOKOSZKA (Warsaw)
  • Márta KORBONITS (London)
  • Asim KURJAK (Zagreb)
  • Manfred MAIER (Wien)
  • Lajos OKOLICSÁNYI (Padova)
  • Amado Salvador PENA (Amsterdam)
  • Guliano RAMADORI (Goettingen)
  • Olivér RÁCZ (Košice)
  • Roberto ROMERO (Detroit)
  • Rainer SCHÖFL (Linz)
  • Zvi VERED (Tel Aviv)
  • Josef VESELY (Olomouc)
  • Ákos ZAHÁR (Hamburg)

Akadémiai Kiadó Zrt. 1117 Budapest
Budafoki út 187-189.
A épület, III. emelet
Phone: (+36 1) 464 8235
Email: orvosihetilap@akademiai.hu

  • Web of Science SCIE
  • Scopus
  • Medline
  • CABELLS Journalytics

2023  
Web of Science  
Journal Impact Factor 0.8
Rank by Impact Factor Q3 (Medicine, General & Internal)
Journal Citation Indicator 0.2
Scopus  
CiteScore 1.2
CiteScore rank Q3 (General Medicine)
SNIP 0.343
Scimago  
SJR index 0.214
SJR Q rank Q4

Orvosi Hetilap
Publication Model Hybrid
Submission Fee none
Article Processing Charge 900 EUR/article
Printed Color Illustrations 20 EUR (or 5000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2025 Online subsscription: 962 EUR / 1157 USD
Print + online subscription: 1092 EUR / 1352 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Orvosi Hetilap
Language Hungarian
Size A4
Year of
Foundation		 1857
Volumes
per Year		 1
Issues
per Year		 52
Founder Markusovszky Lajos Alapítvány -- Lajos Markusovszky Foundation
Founder's
Address		 H-1088 Budapest, Szentkriályi u. 46.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 0030-6002 (Print)
ISSN 1788-6120 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2024 16 0 0
Jul 2024 17 0 0
Aug 2024 9 0 1
Sep 2024 23 0 0
Oct 2024 98 0 0
Nov 2024 41 0 0
Dec 2024 3 0 0